Cargando…
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially vulnerable to coronavirus disease 19 (COVID-19), because of their profound immunodeficiency. Indeed, the first pandemic wave was marked by a high mortality rate in this population. Factors increasing immunodepre...
Autores principales: | Bordat, Jonathan, Maury, Sébastien, Leclerc, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993088/ https://www.ncbi.nlm.nih.gov/pubmed/36911678 http://dx.doi.org/10.3389/fimmu.2023.1100468 |
Ejemplares similares
-
Breakthrough Covid‐19 infections in vaccinated recipients of allogeneic stem cell transplantation
por: Fourati, Slim, et al.
Publicado: (2022) -
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020) -
The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
por: Ktena, Yiouli P., et al.
Publicado: (2023) -
The two-step approach to allogeneic hematopoietic stem cell transplantation
por: Ibikunle, Sikemi, et al.
Publicado: (2023) -
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)